Elobixibat and its potential role in chronic idiopathic constipation. Acosta A, Camilleri M. Therap Adv Gastroenterol. 2014 Jul;7(4):167-75. doi: 10.1177/1756283X14528269. PMID: 25057297
Latest development in the synthesis of ursodeoxycholic acid (UDCA): a critical review. Tonin F, Arends IWCE. Beilstein J Org Chem. 2018 Feb 20;14:470-483. doi: 10.3762/bjoc.14.33. eCollection 2018. PMID: 29520309
Pharmacy Compounded Medicines for Patients With Rare Diseases: Lessons Learned From Chenodeoxycholic Acid and Cholic Acid. Polak Y, Jacobs BAW, Kemper EM. Front Pharmacol. 2021 Sep 28;12:758210. doi: 10.3389/fphar.2021.758210. eCollection 2021. PMID: 34650439
Human-specific dual regulations of FXR-activation for reduction of fatty liver using . Miyazaki T, Honda A, Ikegami T, Iida T, Matsuzaki Y. J Clin Biochem Nutr. 2019 Mar;64(2):112-123. doi: 10.3164/jcbn.18-80. Epub 2018 Nov 28. PMID: 30936623
Review of efficacy and safety of laxatives use in geriatrics. Izzy M, Malieckal A, Little E, Anand S. World J Gastrointest Pharmacol Ther. 2016 May 06;7(2):334-42. doi: 10.4292/wjgpt.v7.i2.334. PMID: 27158549